Lacteol: Clinical Trials

15 trials of Lacteol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 3 unknown, 2 terminated, 1 enrolling by invitation. 15 Phase 2, 5 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 215Completed 8, Unknown 3, Terminated 2, Enrolling by invitation 1, Withdrawn 1
Phase 15Completed 2, Unknown 2, Enrolling by invitation 1
Phase 31Completed 1

Follow Lacteol: new trials by email Literature Review of Lacteol trials Research Report on Lacteol

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety of Lactobacillus LB Postbiotic in Immunocompromised Paediatric Patients With Diarrhoeal Disease
Lactobacillus LB - Diarrhea
Phase 1 / Phase 2Enrolling by invitationHospital Infantil de Mexico Federico Gomez302026-09-012026-11-12
The Effectiveness of Probiotics in Neonatal Jaundice
Probiotic Formula - Jaundice, Neonatal
Phase 1 / Phase 2UnknownTanta University442024-07-012024-06-10
Clinical Study Evaluating the Safety of Lactobacillus Probiotic in Children With Drug Resistant Epilepsy
Lactobacillus-Based Capsule - Drug Resistant Epilepsy
Phase 2CompletedTanta University602022-09-252025-07-01
Probiotics and Corticosteroids for Treating Periodic Fever, Aphthous Stomatitis, Pharyngitis, Cervical Adenitis (PFAPA)
Lactobacillus acidophilus and Bifidobacterium lactis, Placebo - Periodic Fever, Aphthous Stomatitis
Phase 2WithdrawnConnecticut Children's Medical Center2016-10-012018-01-24
A Study of IBRF Disorders of Consciousness Advanced Care/MultiModal Care Protocol in Severe Disorders of Consciousness
Polypharmacy using FDA-approved products, Median Nerve Stimulation (MNS), Nutraceutical Supplementation - Brain Injury
Phase 1 / Phase 2UnknownInternational Brain Research Foundation302016-03-012016-09-02
Impact of Probiotics on Urinary Symptoms in Spinal Cord Injury SCI and SB
Lactobacillus - Lower Urinary Tract Symptoms
Phase 2CompletedMedstar Health Research Institute72016-01-012020-04-24
Safety, Tolerability and Host Response to Lactobacillus Johnsonii
L. johnsonii N6.2, Placebo - Healthy
Phase 1 / Phase 2CompletedUniversity of Florida422015-08-012018-06-14
The Effects of Probiotic Supplementation on Markers of Muscle Damage and Performance Following Exercise Induced Muscle Damage
Lactic acid bacteria and bifidobacteria, Placebo - Probiotics
Phase 2CompletedTexas Christian University152015-02-012016-10-19
Pilot Study of the Effectiveness of Probiotics and Lactitol for the Decolonization of OXA-48 (Carbapenemase) Producing Klebsiella Pneumoniae Among Rectal Carriers
Lactitol, Lactobacillus - Bacterial Colonization
Phase 2UnknownInstituto de Investigación Hospital Universitario La Paz202014-10-012014-12-05
Effect of Probiotic Supplement in Alleviating Functional Gastrointestinal Symptoms
Probiotic (Active high), Probiotic (Active low), Placebo - Irritable Bowel Syndrome
Phase 2CompletedDanisco3912012-10-012016-01-26
Efficacy and Safety of Lactobacillus Acidophilus/Rhamnosus Combination for the Prevention of Antibiotic-associated Diarrhea in the Elderly
Lactobacillus acidophilus/rhamnosus, Placebo - Diarrhea, Clostridium Difficile
Phase 2TerminatedVancouver Island Health Authority72011-09-012013-12-19
Effect of Probiotic Supplement on Bowel Function
Probiotic supplement - Irritable Bowel Syndrome
Phase 2TerminatedDanisco1492011-06-012015-08-13
Probiotic Intervention With Elderly Subjects
Probiotic - Intestinal C. Difficile
Phase 2CompletedDanisco1042011-01-012016-01-27
Probiotics for the Prevention of Antibiotics Associated Diarrhoea and Clostridium Difficile Associated Diarrhoea
VSL#3, Placebo - Diarrhoea
Phase 2 / Phase 3CompletedNational Health Service, United Kingdom2312010-04-012013-04-26
Probiotics for Birch Pollen Allergy
Lactobacillus acidophilus and Bifidobacterium lactis, Placebo - Rhinitis, Allergic, Seasonal
Phase 1 / Phase 2CompletedDanisco472006-03-012008-09-03

Conditions studied

Diarrhea (5)  ·  Constipation (2)  ·  Irritable Bowel Syndrome (2)  ·  Brain Injuries (1)  ·  Coma (1)  ·  Consciousness Disorders (1)  ·  Drug Resistant Epilepsy (1)  ·  Hereditary Autoinflammatory Diseases (1)  ·  Jaundice, Neonatal (1)  ·  Lower Urinary Tract Symptoms (1)  ·  Pain (1)  ·  Persistent Vegetative State (1)  ·  Pharyngitis (1)  ·  Rhinitis, Allergic, Seasonal (1)  ·  Spinal Cord Injuries (1)

Sponsors

Danisco (4)  ·  Tanta University (2)  ·  Connecticut Children's Medical Center (1)  ·  Hospital Infantil de Mexico Federico Gomez (1)  ·  Instituto de Investigación Hospital Universitario La Paz (1)  ·  International Brain Research Foundation (1)  ·  Medstar Health Research Institute (1)  ·  National Health Service, United Kingdom (1)  ·  Texas Christian University (1)  ·  University of Florida (1)  ·  Vancouver Island Health Authority (1)

Countries

Finland (4)  ·  United States (4)  ·  Canada (1)  ·  Egypt (1)  ·  Mexico (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Anna Lyra, PhD (3)  ·  Sampo Lahtinen, PhD (3)  ·  Arthur Ouwehand, PhD (2)  ·  Lea Veijola, MD (2)  ·  Amira Rashdan, Rashdan (1)  ·  Anneli Tarpila, PhD (1)  ·  Arthur C Ouwehand, PhD (1)  ·  Curtis Harder, BSc. Pharm, ACPR, Pharm D (1)  ·  Francisco Arnalich, PhD (1)  ·  Hans Pohl, MD (1)  ·  Matti Viitanen, MD (1)  ·  Neil Haslam (1)  ·  Nicholas Bennett, MBBChir PhD (1)  ·  Philip A Defina, Ph.D. (1)  ·  Rodrigo Vazquez-Frias (1)

Results publications

PMID 23618760, PMID 27754427, PMID 28659913, PMID 32280375, PMID 41693686